Summary of Key Points
Tongrentang Medical Care (the core platform for traditional Chinese medicine (TCM) medical services under Beijing Tongrentang Group) will be listed on the Hong Kong Stock Exchange on July 7th, offering 108 million H shares to the public. Among them, cornerstone investors account for nearly 47%, providing stable support for the stock price. Leveraging its brand history of over 350 years, the company has become a leader in the domestic private TCM sector by adopting a model that combines franchising, digital technology, and low-cost operations. It benefits from the growing demand for TCM medical services driven by an aging population (the market is expected to reach 1.69 trillion yuan by 2030). The company has also invested in AI technology to transition from treating diseases to preventing them. The listing was previously delayed, but now the timing is ripe.
Detailed Analysis
1. **Listing Details: Cornerstone Investors Provide Stability**
The H shares offered for sale include 10.81 million shares for local Hong Kong investors (10%) and 97.33 million shares for international markets (90%). The significant presence of cornerstone investors (such as sovereign funds and renowned investment firms) indicates their confidence in the company's value, which helps to stabilize the stock price after listing.
Why choose now to list? On one hand, the industry is in a period of growth; on the other hand, the company’s financial performance is strong (for example, the number of patients has nearly doubled in three years), making it possible to obtain a better valuation at this time.
2. **Industry Trends: Aging Population Boosts TCM Demand**
The number of people aged 60 and above in China has exceeded 300 million. The main needs of this demographic include chronic disease management, wellness therapies (such as massage and acupuncture), and preventive healthcare. According to third-party data, the TCM market will exceed one trillion yuan by 2025, with an annual growth rate of 9.5%.
This means that Tongrentang Medical Care is in a position of advantage, as it addresses a rapidly growing demand for TCM services.
3. **Leadership Position: Strong Franchise Network and Digital Advantages**
Tongrentang Medical Care is the leading private TCM institution in China:
- Patient Volume: It will rank first in patient volume by 2025 (1.5% market share) and second in revenue (0.2%).
- Strengths:
- Expertise: It has 2,758 practicing physicians, including 30 national-level honor doctors.
- Network: It operates 13 own hospitals, 1 internet hospital, and manages another 13 hospitals, covering the entire country, with specialized services in heart and brain diseases.
- Digital Tools: It uses cloud systems to manage medical quality and costs. The internet hospital offers online follow-up consultations and medication delivery (in collaboration with over 500 pharmacies, allowing electronic prescriptions to be sent directly to nearby stores). By 2025, it expects 324,000 online consultations.
- User Growth: Patient volume is expected to increase from 1.8 million to 3.4 million (39.4% annual growth) between 2023 and 2025, with the number of members rising from 530,000 to 770,000.
4. **Brand and Business Model: A Time-Honored Brand with Cost-Effective Operations**
The "Tongrentang" brand is a significant asset, as it enjoys trust due to its long history (over 350 years). As a result, the company’s marketing expenses are low—only 0.16% of revenue in 2025, compared to an industry average of 0.5%-2%. Its business model is also efficient:
- Multiple Revenue Streams: It offers TCM medical services, management consulting for other hospitals, and TCM products.
- Low-Cost Expansion: The company expands by acquiring existing institutions or managing non-profit hospitals, with a high gross margin on management services (71.9%).
- Hierarchical Care: Its network of hospitals, grassroots clinics, and internet hospitals provides seamless services, enhancing customer loyalty.
5. **AI Integration: Enhancing Traditional TCM with Technology**
Tongrentang Medical Care is embracing AI to innovate its services:
- AI Wellness Centers: Collaborating with Xiaomi to provide intelligent services from health consultations to personalized advice and medication guidance.
- AI in TCM Drug Development: Partnering with the Beijing Municipal Bureau of Economy and Information Technology to develop a large database of TCM formulas and accelerate new drug research.
- Smart Health Management: Using AI for customized health monitoring and wellness recommendations, such as automated reminders for lifestyle adjustments based on blood pressure measurements. This shift from treating diseases to preventing them aligns with future trends in TCM services, potentially attracting more healthy individuals and expanding the market.
Conclusion
With its century-old brand, leading position, and innovative use of AI, Tongrentang Medical Care is well-positioned for the growing TCM market. Whether it can continue to generate profits depends on its ability to leverage these advantages to attract more customers and increase profitability. (Investment involves risks; this analysis is for reference only.)